BCL2L1 and lymphoma: These lymphoma lines were treated in culture with a range of concentrations of the BH3-mimetic drugs S63845 (MCL-1 inhibitor [31]) and ABT-737 (inhibitor of BCL-2 + BCL-XL + BCL-W [8]).